ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor

1. Li, D.
2. March, M.E.
3. Gutierrez-Uzquiza, A.
4. Kao, C.
5. Seiler, C.
6. Pinto, E.
7. Matsuoka, L.S.
8. Battig, M.R.
9. Bhoj, E.J.
10. Wenger, T.L.
11. Tian, L.
12. Robinson, N.
13. Wang, T.
14. Liu, Y.
15. Weinstein, B.M.
16. Swift, M.
17. Jung, H.M.
18. Kaminski, C.N.
19. Chiavacci, R.
20. Perkins, J.A.
21. Levine, M.A.
22. Sleiman, P.M.A.
23. Hicks, P.J.
24. Strausbaugh, J.T.
25. Belasco, J.B.
26. Dori, Y.
27. Hakonarson, H.
28. Mostrar todos los/as autores/as +